Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Life Time $699 million secondary offering
The shares are listed on the New York Stock Exchange
Live Oak Acquisition V $230 million IPO
The units are listed on the Nasdaq Global Market
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Rithm Acquisition $230 million SPAC IPO
We advised Rithm Acquisition Corp., a SPAC, on its IPO and NYSE listing
Mastercard $1.25 billion senior notes offering
We advised Mastercard on its investment-grade debt offering
AbbVie $4 billion senior notes offering
The investment-grade notes are due 2028, 2030, 2035 and 2055
Pacific Gas and Electric $1.75 billion first-mortgage bonds offering
The investment-grade bonds are due 2035 and 2055
Altisource exchange and maturity extension
We advised an ad hoc group of term loan lenders on the transaction
Rollins $500 million debut senior notes offering
The investment-grade notes are due 2035
Cisco Systems $5 billion notes offering
The investment-grade offering comprises five tranches of notes